Treatment Recommendations for Locally Advanced, Non-Small-Cell Lung Cancer: The Influence of Physician and Patient Factors

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 5, 2009, Pages 1376-1384

  Lee, Irwin H ^a   Hayman, James A ^a   Landrum, Mary Beth ^b   Tepper, Joel ^c   Tao, May Lin ^d   Goodman, Karyn A ^e   Keating, Nancy L ^b,f  

^a UNIVERSITY OF MICHIGAN   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d Epic Care   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Comorbidity; Non small cell lung cancer; Patient age; Radiation; Recommendations

Indexed keywords

CHEMORADIATION; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CLINICAL TRIAL; COMORBID ILLNESS; COMORBIDITY; LUNG CANCER; MULTINOMIAL LOGISTIC REGRESSION; NON-SMALL-CELL LUNG CANCER; PATIENT AGE; PULMONARY FUNCTION; RADIATION ONCOLOGISTS; RECOMMENDATIONS;

BIOLOGICAL ORGANS; CELL MEMBRANES; CHEMOTHERAPY; EPIDEMIOLOGY; RADIATION;

PATIENT TREATMENT;

ADVANCED CANCER; AGE DISTRIBUTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE SEVERITY; EVIDENCE BASED PRACTICE; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; MEDICAL PRACTICE; MEDICAL SPECIALIST; PRIORITY JOURNAL; TREATMENT PLANNING;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH CARE SURVEYS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROFESSIONAL PRACTICE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIATION ONCOLOGY; SMOKING; YOUNG ADULT;

EID: 67651085596     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.066     Document Type: Article

References (28)

1. Dillman R.O., Herndon J., Seagren S.L., et al. Improved survival in Stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 88 (1996) 1210-1215
2. Schaake-Koning C., van den Bogaert W., Dalesio O., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326 (1992) 524-530
3. Sause W., Kolesar P., Taylor S.I., et al. Final results of Phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 117 (2000) 358-364
4. Jett J.R., Schild S.E., Keith R.L., et al. Treatment of non-small cell lung cancer, Stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132 (2007) 266S-276S
5. Okawara G., Mackay J.A., Evans W.K., et al. Management of unresected Stage III non-small cell lung cancer: A systematic review. J Thorac Oncol 1 (2006) 377-193
6. Pfister D.G., Johnson D.H., Azzoli C.G., et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003. J Clin Oncol 22 (2004) 330-353
7. Ettinger DS, Akerley W, Bepler G, et al. NCCN Practice Guidelines in Oncology: Non-small Cell Lung Cancer v.2.2008. Available at: http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf. Accessed May 12, 2008.
8. Rocha Lima C.M., Herndon II J.E., Kosty M., et al. Therapy choices among older patients with lung carcinoma: An evaluation of two trials of the Cancer and Leukemia Group B. Cancer 94 (2002) 181-187
9. Schild S.E., Stella P.J., Geyer S.M., et al. The outcome of combined-modality therapy for Stage III non-small-cell lung cancer in the elderly. J Clin Oncol 21 (2003) 3201-3206
10. Movsas B., Moughan J., Komaki R., et al. Radiotherapy patterns of care study in lung carcinoma. J Clin Oncol 21 (2003) 4553-4559
11. Langer C.J., Moughan J., Movsas B., et al. Patterns of care survey (PCS) in lung cancer: How well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?. Lung Cancer 48 (2005) 93-102
12. Gopal R., Starkschall G., Tucker S.L., et al. Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 56 (2003) 114-120
13. Mao J., Kocak Z., Zhou S., et al. The impact of induction chemotherapy and the associated tumor response on subsequent radiation-related changes in lung function and tumor response. Int J Radiat Oncol Biol Phys 67 (2007) 1360-1369
14. Rancati T., Ceresoli G.L., Gagliardi G., et al. Factors predicting radiation pneumonitis in lung cancer patients: A retrospective study. Radiother Oncol 67 (2003) 275-283
15. Ayanian J.Z., Chrischilles E.A., Fletcher R.H., et al. Understanding cancer treatment and outcomes: The Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol 22 (2004) 2992-2996
16. National Cancer Institute. Cancer Care Outcomes Research and Surveillance Consortium. 2007. Available at: http://healthservices.cancer.gov/cancors/. Accessed September 7, 2007.
17. Keating N.L., Landrum M.B., Klabunde C.N., et al. Adjuvant chemotherapy for Stage III colon cancer: Do physicians agree about the importance of patient age and comorbidity?. J Clin Oncol 26 (2008) 2532-2537
18. Little R.J. Statistical analysis with missing data, 2nd edtion (2002), Wiley, New York
19. He Y., Zaslavsky A.M., Harrington D.P., et al. Imputation in a multiformat and multiwave survey of cancer care. Stat Methods Med Res (2008) In press
20. Little R.J. Direct standardization: A tool for teaching linear models for unbalanced data. Am Statistician 36 (1982) 38-43
21. Le Chevalier T., Arriagada R., Quoix E., et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83 (1991) 417-423
22. Movsas B., Scott C., Sause W., et al. The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): A quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies. Int J Radiat Oncol Biol Phys 45 (1999) 1143-1149
23. Langer C.J., Hsu C., Curran W.J., et al. Elderly patients (pts) with locally advanced non-small cell lung cancer (LA-NSCLC) benefit from combined modality therapy: Secondary analysis of Radiation Therapy Oncology Group (RTOG) 94-10. Proc Am Soc Clin Oncol 21 (2002) (abstract 1193)
24. Hillner B.E., Smith T.J., and Desch C.E. Hospital and physician volume or specialization and outcomes in cancer treatment: Importance in quality of cancer care. J Clin Oncol 18 (2000) 2327-2340
25. Lee J.S., Scott C.B., Komaki R., et al. Impact of institutional experience on survival outcome of patients undergoing combined chemoradiation therapy for inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52 (2002) 362-370
26. Peabody J.W., Luck J., Glassman P., et al. Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med 141 (2004) 771-780
27. Curran W.J., Scott C.B., Langer C.J., et al. Long-term benefit is observed in a Phase III comparison of sequential vs concurrent chemoradiation for patients with unresected Stage III NSCLC: RTOG 9410. Proc Am Soc Clin Oncol 22 (2003) 621
28. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable Stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699